18,19-dihydroetorphine has been researched along with Body Weight in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Miao, H; Qin, BY | 1 |
Kaneto, H; Takahashi, M; Tokuyama, S | 1 |
Bai, HQ; Li, N; Li, Y; Wu, WR; Zhang, KR; Zheng, JW | 1 |
Aceto, MD; Harris, LS; Ji, Z; Scates, SM | 1 |
4 other study(ies) available for 18,19-dihydroetorphine and Body Weight
Article | Year |
---|---|
Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
Topics: Animals; Body Weight; Etorphine; Female; Locus Coeruleus; Male; Morphine Dependence; Neurons; Opioid-Related Disorders; Rats; Rats, Wistar; Reserpine; Substance Withdrawal Syndrome | 1995 |
Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
Topics: Analgesics; Animals; Body Weight; Drug Tolerance; Etorphine; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Substance-Related Disorders | 1993 |
Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
Topics: Analgesics, Opioid; Animals; Antibody-Producing Cells; Body Weight; Cell Division; Dose-Response Relationship, Drug; Etorphine; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Lymphokines; Mice; Mice, Inbred C57BL; Naloxone; Opioid-Related Disorders; Organ Size; Spleen; Substance Withdrawal Syndrome; Thymus Gland | 1999 |
Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Etorphine; Infusions, Parenteral; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2000 |